Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of histone modifiers to reprogram effector T cells

Use of histone modifiers to reprogram effector T cells

US Patent 12173317 · Granted Dec 24, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Expansion culture method for human-derived natural killer cells by using HDAC in2025
Methods for production of tissue resident memory-like T cells and use thereof2025
T cell receptors with mage-B2 specificity and uses thereof2025
T cell receptors for immunotherapy2024
Use of Chaetomium globosum strain in controlling fusarium crown rot of wheat2024
HLA-restricted VCX/Y peptides and T cell receptors and use thereof2023
HLA-restricted VGLL1 peptides and use thereof in promoting an immune response in2023
Methods of using IL-21 for adoptive immunotherapy and identification of tumor an2022
Enhanced generation of cytotoxic T-lymphocytes by IL-21 mediated FOXP3 suppressi2021
Methods of treatment using conditional superagonist CTL ligands for the promotio2021
Method of obtaining cytolytic T cells by using mutant tumor epitopes2019
Enhanced generation of cytotoxic T lymphocytes by IL-21 mediated FoxP3 suppressi2018